Search
Search Results
##search.searchResults.foundPlural##
-
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1359PDF: 829HTML: 5041INSTITUTE PUBLICATION COMMITTEE APPROVAL: 163 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1696PDF: 1187HTML: 229 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4674PDF: 1326HTML: 1917Untitled: 182Untitled: 177 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1129PDF: 803HTML: 212 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3989PDF: 1516HTML: 9191Untitled: 280Untitled: 187Untitled: 172Untitled: 165Untitled: 186Untitled: 341 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1468PDF: 910HTML: 2214Response to reviewers comments: 181 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3160PDF: 1141HTML: 1491Untitled: 179Untitled: 171Untitled: 171 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2593PDF: 804HTML: 5220 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
785PDF: 91HTML: 143 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
1923PDF: 955Html: 325 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2228PDF: 966HTML: 1900 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3596PDF: 1643HTML: 2677 -
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4790PDF: 2846HTML: 2294 -
IMMUNOLOGY OF TUBERCULOSIS
5332PDF: 2015HTML: 7323Untitled: 195 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3176PDF: 1117HTML: 1766 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
198PDF: 228Suppl. Files: 38HTML: 19 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1209PDF: 1074HTML: 205 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1234PDF: 594HTML: 2865ATRA induced Reactive Hemophagocytosis: A Case Report: 199 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
489PDF: 250HTML: 79 -
-
MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.
1225PDF: 603HTML: 218 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3046PDF: 1027HTML: 3084 -
-
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2246PDF: 612Suppl. Files: 283HTML: 174 -
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1222PDF: 834HTML: 77 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3523PDF: 893HTML: 1656figure 1: 168Untitled: 192 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2140PDF: 1703HTML: 380







